Literature DB >> 16338016

High expression level of recombinant human erythropoietin in the milk of non-transgenic goats.

Jorge R Toledo1, Oliberto Sánchez, Raquel Montesino Seguí, Gerardo García, Margela Montañez, Pastor A Zamora, María P Rodríguez, José A Cremata.   

Abstract

The high degree of structural conservation of erythropoietin between species, make it, especially, difficult to produce this protein growth factor in the milk of transgenic animals. Here, we show that through the direct transduction of the mammary epithelium, it is possible to produce high levels of recombinant human erythropoietin in the milk of non-transgenic goats without causing harm to the animals. The efficiency of viral transduction was improved through a temporal disruption of tight-junctions with EGTA allowing for the expression of human erythropoietin at levels of up to 2g/L in milk. The human erythropoietin was purified from the milk using a multi-step protocol involving milk clarification, two precipitation steps and two affinity chromatographies, with a yield of about 70% and purity over 98%. However, the human erythropoietin expressed in milk was underglycosylated, which seems to be the main cause for its low in vivo hematopoietic activity. Nonetheless, these results demonstrate that through the direct transduction of the mammary epithelium it is possible to produce potentially toxic proteins in milk, at levels high enough for their purification and biological characterization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338016     DOI: 10.1016/j.jbiotec.2005.10.019

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  18 in total

Review 1.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

2.  N-Glycosylation engineering of tobacco plants to produce asialoerythropoietin.

Authors:  Farooqahmed S Kittur; Chiu-Yueh Hung; Diane E Darlington; David C Sane; Jiahua Xie
Journal:  Plant Cell Rep       Date:  2012-02-28       Impact factor: 4.570

Review 3.  Transgenesis applied to goat: current applications and ongoing research.

Authors:  Laurent Boulanger; Bruno Passet; Eric Pailhoux; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2012-04-20       Impact factor: 2.788

4.  Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse.

Authors:  Tonia S Rex; Ying Wong; Kishore Kodali; Shayla Merry
Journal:  Exp Eye Res       Date:  2009-07-08       Impact factor: 3.467

Review 5.  Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease.

Authors:  Dapinder Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vishnu Nayak Badavath; Syed Shams Ul Hassan; Mohammad Mehedi Hasan; Saurabh Bhatia; Ahmed Al-Harassi; Haroon Khan; Simona Bungau
Journal:  Metab Brain Dis       Date:  2021-08-26       Impact factor: 3.584

6.  Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?

Authors:  Zuyong He; Yiqiang Zhao; Gui Mei; Ning Li; Yaosheng Chen
Journal:  Transgenic Res       Date:  2010-06-19       Impact factor: 2.788

7.  Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model.

Authors:  Hai Yang; Qing-Wang Li; Zeng-Sheng Han; Jian-Hong Hu; Wen-Ye Li; Zhi-Bin Liu
Journal:  J Thromb Thrombolysis       Date:  2009-05-20       Impact factor: 2.300

8.  Transient Expression of Functional Glucocerebrosidase for Treatment of Gaucher's Disease in the Goat Mammary Gland.

Authors:  Kaio Cesar Simiano Tavares; Ana Christina de Oliveira Dias; Cícera Regina Lazzarotto; Saul Gaudencio Neto; Igor de Sá Carneiro; Felipe Ledur Ongaratto; Antônio Frederico Michel Pinto; Luís Henrique de Aguiar; Carlos Enrique Mendez Calderón; Jorge Roberto Toledo; Fidel Ovidio Castro; Diogenes Santiago Santos; Jocelei Maria Chies; Marcelo Bertolini; Luciana Relly Bertolini
Journal:  Mol Biotechnol       Date:  2016-01       Impact factor: 2.695

9.  Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.

Authors:  Pasqualina Colella; Carolina Iodice; Umberto Di Vicino; Ida Annunziata; Enrico M Surace; Alberto Auricchio
Journal:  Hum Mol Genet       Date:  2011-03-19       Impact factor: 6.150

10.  Use of transgenic animals in biotechnology: prospects and problems.

Authors:  O G Maksimenko; A V Deykin; Yu M Khodarovich; P G Georgiev
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.